» Articles » PMID: 17447434

Metal Specificity of an Iron-responsive Element in Alzheimer's APP MRNA 5'untranslated Region, Tolerance of SH-SY5Y and H4 Neural Cells to Desferrioxamine, Clioquinol, VK-28, and a Piperazine Chelator

Overview
Date 2007 Apr 24
PMID 17447434
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Iron closely regulates the expression of the Alzheimer's Amyloid Precursor Protein (APP) gene at the level of message translation by a pathway similar to iron control of the translation of the ferritin L- and H mRNAs by Iron-responsive Elements in their 5' untranslated regions (5'UTRs). Using transfection based assays in SH-SY5Y neuroblastoma cells we tested the relative efficiency by which iron, copper and zinc up-regulate IRE activity in the APP 5'UTR. Desferrioxamine (high affinity Fe3+ chelator), (ii) clioquinol (low affinity Fe/Cu/Zn chelator), (iii) piperazine-1 (oral Fe chelator), (iv) VK-28 (oral Fe chelator), were tested for their relative modulation of APP 5' UTR directed translation of a luciferase reporter gene. Iron chelation based therapeutic strategies for slowing the progression of Alzheimer's disease (and other neurological disorders that manifest iron imbalance) are discussed with regard to the relative neural toxic action of each chelator in SH-SY5Y cells and in H4 glioblastoma cells.

Citing Articles

Targeting Iron Responsive Elements (IREs) of APP mRNA into Novel Therapeutics to Control the Translation of Amyloid-β Precursor Protein in Alzheimer's Disease.

Khan M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770511 PMC: 11677800. DOI: 10.3390/ph17121669.


Iron and Targeted Iron Therapy in Alzheimer's Disease.

Wang J, Fu J, Zhao Y, Liu Q, Yan X, Su J Int J Mol Sci. 2023; 24(22).

PMID: 38003544 PMC: 10671546. DOI: 10.3390/ijms242216353.


Iron response elements (IREs)-mRNA of Alzheimer's amyloid precursor protein binding to iron regulatory protein (IRP1): a combined molecular docking and spectroscopic approach.

Khan M, Mohammad T, Malik A, Hassan M, Domashevskiy A Sci Rep. 2023; 13(1):5073.

PMID: 36977734 PMC: 10050399. DOI: 10.1038/s41598-023-32073-x.


Secondary White Matter Injury Mediated by Neuroinflammation after Intracerebral Hemorrhage and Promising Therapeutic Strategies of Targeting the NLRP3 Inflammasome.

Xiao L, Wang M, Shi Y, Xu Y, Gao Y, Zhang W Curr Neuropharmacol. 2022; 21(3):669-686.

PMID: 36043798 PMC: 10207923. DOI: 10.2174/1570159X20666220830115018.


Dysregulation of Neuronal Iron in Alzheimer's Disease.

Uddin M, Ashraf G Curr Neuropharmacol. 2021; 21(11):2247-2250.

PMID: 34970955 PMC: 10556378. DOI: 10.2174/1570159X20666211231163544.